Saccheri, Clément
Morawiec, Elise
Delemazure, Julie
Mayaux, Julien
Dubé, Bruno-Pierre
Similowski, Thomas
Demoule, Alexandre
Dres, Martin
Funding for this research was provided by:
Société de Réanimation de Langue Française
Article History
Received: 5 October 2019
Accepted: 16 December 2019
First Online: 3 January 2020
Ethics approval and consent to participate
: Human research ethics committee approval for the study was provided by the Comité de Protection des Personnes - Ile de France 6.
: Patients or their next of kin gave informed consent.
: AD reports personal fees and non-financial support from Medtronic; grants, personal fees and non-financial support from Philips; personal fees from Baxter; personal fees from Hamilton; grants and non-financial support from Fisher & Paykel; grants from the French Ministry of Health. MD received personal fees from Lungpacer Inc. BPD received personal fees from Grifols, Boehringer Ingelheim and Roche, and has signed clinical research contracts with Sanofi, Roche and Boehringer Ingelheim. Thomas Similowski has received personal fees from Lungpacer Inc. and is a member of the board of a research association that has received, over the past ten years, unrestricted research grants from Maquet, Hamilton, Covidien, and Philips. He is the head of a research unit (UMRS 1158) that has signed research contracts with Air Liquide Medical Systems, France; he is listed as inventor or co-inventor on several patents, granted or pending, describing a brain–ventilator interface. LB’s Research Laboratory received research grants from Covidien, General Electric, Fisher Paykel, Maquet (with St Michael’s Hospital) and Philips. The other authors have no conflict of interest to disclose.